
    
      Purpose: The purpose of this trial is to evaluate the acute safety and effectiveness of the
      SAPIEN XT™ study valve and next generation Ascendra™ delivery components.

      Follow-up Intervals: Subject data collection will include clinical information at baseline
      and during the index procedure. Subjects will undergo clinical follow-up at discharge, 30
      days, 6 month annually for 5 years.
    
  